Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
2021 · Journal of Experimental & Clinical Cancer Research · 502 citations
https://doi.org/10.1186/s13046-021-01987-7
Z
Zhixiong Liu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
192
Papers
8.3K
Citations
44
h-index
96
i10-index
Zhixiong Liu is an academic researcher from Central South University. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Ferroptosis and cancer prognosis & Immune cells in cancer. The author has an h-index of 44, co-authored 164 publications.
ORCID: 0000-0002-0288-6306Papers by this author
worksClinical practice guidelines for the management of adult diffuse gliomas
2020 · Cancer Letters · 454 citations
https://doi.org/10.1016/j.canlet.2020.10.050
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
2022 · Journal of Hematology & Oncology · 257 citations
https://doi.org/10.1186/s13045-022-01325-0
The molecular feature of macrophages in tumor immune microenvironment of glioma patients
2021 · Computational and Structural Biotechnology Journal · 142 citations
https://doi.org/10.1016/j.csbj.2021.08.019
The adaptive transition of glioblastoma stem cells and its implications on treatments
2021 · Signal Transduction and Targeted Therapy · 135 citations
https://doi.org/10.1038/s41392-021-00491-w
Tumor treating fields for high-grade gliomas
2020 · Biomedicine & Pharmacotherapy · 64 citations
https://doi.org/10.1016/j.biopha.2020.110193
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat